- Home
- Applications
- diagnostics technology for diagnostics medical
Show results for
Refine by
Diagnostics Technology For Diagnostics Medical Product Applications For The Served Medical Health Care Industry
10 applications found
The global diagnostics sector continues to grow by 4% per annum and that means more biohazardous laboratory waste will be generated. ...
ByEnvetec Sustainable Technologies based in Co. Tipperary, IRELAND
FHT products and technology can be used in analytical and diagnostic devices in the medical ...
ByFluidic High Technology (FHT) based in Wayne, NEW JERSEY (USA)
1 in 6 adults aged 65 or older are affected by depression1. This behavioral health condition is a significant driver of direct healthcare costs. Things such as diet, insecure living conditions or loneliness can exacerbate depression, and lead patients to make poor lifestyle choices that negatively impact their health and wellbeing. ...
ByBiomedix based in Saint Paul, MINNESOTA (USA)
Use low energy radioisotopes which allow physicians to see and measure disease within the body, via ...
ByRadiopharm Theranostics based in Carlton, AUSTRALIA
Meeting the growing need for higher performing materials for medical devices, in-vitro diagnostics and pharmaceutical packaging. From our experience in multiple industries and consultation with regulatory experts, Ampacet has developed a new portfolio of medical grade masterbatch solutions. Our extensive testing program helps customers meet all performance criteria and compliance with the increasingly stringent requirements of regulatory agencies. For more information about Ampacet medical grade ...
ByAmpacet Corporation based in Tarrytown, NEW YORK (USA)
With the miniaturization and increasingly optimized user friendly of diagnostic devices, self-testing home testing is becoming an increasingly important market. These devices aid to the general well-being of people around the world by making accurate results available immediately and therefore indicating whether subsequent medical treatment is necessary. At LRE, we develop and produce devices for exactly these scenarios, providing easy-to-use and reliable instruments for self-monitoring of lifestyle-associated ...
ByLRE Medical based in Noerdlingen, GERMANY
Point-of-Care Testing at Doctor’s Office, in Hospitals & Clinics, Mobile Testing at Patient Side, Clinical Trials, Govermental Healthcare Programs, NGO based Healthcare Screening Programs (WHO, Unicef) ...
ByChembio Diagnostics GmbH based in Berlin, GERMANY
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood test (FOBT) ...
ByDiagNodus Ltd. based in Cambridge, UNITED KINGDOM
Cancer-targeted molecular probes have the potential to revolutionize surgery and diagnostics. Offering unparalleled flexibility and outstanding performance, FIRE epitomizes the cutting edge of this technology. FIRE’s quenched, substrate-based probe (qSBP) technology guides surgeons by ensuring probe signal is only seen when cancer is detected, clearly delineating tumor tissue from healthy tissue and virtually eliminating spurious background fluorescence common in other probes. ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
Inflammatory bowel disease (IBD), largely comprising the two conditions, Crohn’s Disease and Ulcerative Colitis, is now emerging as a global health problem. It now affects about 6 million people in Europe and US, comprising up to 620,000 in the UK (IBD Standards UK, 2013 Update). The symptoms of diarrhoea, abdominal pain and bloody stool substantially affect the quality of life of sufferers, and complications can be life threatening. IBD is also strongly associated with colorectal cancer development risk. ...
ByDiagNodus Ltd. based in Cambridge, UNITED KINGDOM